Editas Medicine

EDIT • NASDAQ • Stock Fundamentals

Editas Medicine is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Gilmore O'Neill, with a market cap of $374.4M.

Market Cap$374.4M

Employees226.0

CEOGilmore O'Neill

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026

Next EarningsAug 11, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Editas Medicine

Editas Medicine (EDIT) has a market capitalization of $374.4M and trades on NASDAQ.

Editas Medicine has approximately 226 employees.